Vaxart, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -5.16%146.830.0%$1767.59m
NVAXNovavax, Inc. 0.33%232.0092.9%$1427.80m
OCGNOcugen, Inc. -8.77%9.990.0%$1106.99m
AMGNAmgen, Inc. 1.22%227.661.3%$602.04m
ILMNIllumina, Inc. 1.76%447.133.5%$539.44m
REGNRegeneron Pharmaceuticals, Inc. 2.56%462.092.7%$536.28m
VRTXVertex Pharmaceuticals, Inc. 0.13%212.831.9%$516.09m
GILDGilead Sciences, Inc. 1.73%62.461.0%$493.90m
BNGOBioNano Genomics, Inc. 1.95%9.920.0%$381.69m
BIIBBiogen, Inc. 0.07%273.081.7%$380.46m
ALXNAlexion Pharmaceuticals, Inc. 0.33%153.262.0%$372.49m
CRSPCRISPR Therapeutics AG 4.23%131.000.6%$304.35m
EXASEXACT Sciences Corp. 1.91%138.7218.4%$256.88m
VXRTVaxart, Inc. 1.80%7.280.0%$214.40m
SGENSeagen Inc. 0.82%152.355.8%$214.08m

Company Profile

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.